Latest News
01-May-2025 Larger Panel to Review Safety of Ranitidine Despite Susp ension Call
25-Apr-2025 To Speed up Delivery, Govt Exempts Orphan Drugs from Testing at Ports
24-Apr-2025 PLUG SPILL OVER THE COUNTER , says Drugs Panel
23-Apr-2025 Novo Nordisk to Phase Out Key Drug, Insulin Cos Spot Big Biz Opportunity
21-Apr-2025 Pharmacists Seek Clarity on Banned Cough Syrup Stock
  more...
Latest Reports
Apr-25 4QFY25 Preview: Focus on Domestic Plus Margin Variance - Emkay Research  
Apr-25 HSIE Research is also available on Bloomberg ERH HDF & Thomson Reuters Pharma dodges first round of US tariff risk - HDFC Securities  
Jan-25 March of corporate hospitals: Deepening presence - Emkay Research  
Jan-25 US pricing pressure eases; margins improve - Nirmal Bang  
Jan-25 Chemicals/Pharma EXIM trends - Phillip Capital  
  more...

Quarterly Summary September-2024
Desc Current Previous Per.Chg
Sales 67242.7 61013.1 10.2
Otherincome 2488.6 2287.7 8.8
Expense 49904.7 47193.7 5.7
RawMaterial 19003.4 18996.8 0.0
StaffCost 9916.5 9105.9 8.9
ExciseDuty 78.8 58.9 33.9
OtherExp 15371.3 14258.0 7.8
Interest 1058.2 1028.8 2.9
GrossProfit 20070.8 16023.1 25.3
Depreciation 2672.0 2717.1 -1.7
Tax 4076.5 2892.1 41.0
NetProfit 13339.3 10504.1 27.0
Total.Comp 176 -- --
Source: ETIG Database

Sectoral Companies As on 30 Apr 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 439119.89
Divi's Lab 161556.85
Cipla 125157.48
Torrent Phar 112174.25
Mankind Phar 101652.26
Dr.Reddy's 98721.35
Lupin 95631.25
Zydus Life 89320.37
Aurobindo Ph 72030.55
Abbott (I) 63488.52
Alkem Labora 61111.57
GlaxoSmith.P 50136.04
Glenmark Pha 38959.12
  click here for the complete list